Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
Cal H RobinsonMichael Hart-MatyasDaniel A MorgensternDamien NoonePaolo CampisiPublished in: The Annals of otology, rhinology, and laryngology (2023)
Clinicians caring for children treated with VEGF inhibitors should be aware of the potential renal complications and their management.